SE8307060L - Diagnostikum och kontrastmedel - Google Patents

Diagnostikum och kontrastmedel

Info

Publication number
SE8307060L
SE8307060L SE8307060A SE8307060A SE8307060L SE 8307060 L SE8307060 L SE 8307060L SE 8307060 A SE8307060 A SE 8307060A SE 8307060 A SE8307060 A SE 8307060A SE 8307060 L SE8307060 L SE 8307060L
Authority
SE
Sweden
Prior art keywords
subject
contrast
polymer
contractor
diagnostic
Prior art date
Application number
SE8307060A
Other languages
English (en)
Other versions
SE463651B (sv
SE8307060D0 (sv
Inventor
Ulf Schroder
Leif G Salford
Original Assignee
Ulf Schroder
Leif G Salford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20353826&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8307060(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of SE8307060D0 publication Critical patent/SE8307060D0/sv
Priority to SE8307060A priority Critical patent/SE463651B/sv
Application filed by Ulf Schroder, Leif G Salford filed Critical Ulf Schroder
Priority to AT85900253T priority patent/ATE38777T1/de
Priority to EP85900253A priority patent/EP0166755B2/en
Priority to DE8585900253T priority patent/DE3475269D1/de
Priority to JP60500230A priority patent/JPH0755912B2/ja
Priority to PCT/SE1984/000437 priority patent/WO1985002772A1/en
Publication of SE8307060L publication Critical patent/SE8307060L/sv
Priority to NO853270A priority patent/NO164753C/no
Priority to DK377085A priority patent/DK166128C/da
Priority to FI853207A priority patent/FI85815C/sv
Publication of SE463651B publication Critical patent/SE463651B/sv
Priority to SG856/91A priority patent/SG85691G/en
Priority to HK134993A priority patent/HK134993A/xx
Priority to US08/361,466 priority patent/US5618514A/en
Priority to US08/445,945 priority patent/US5670135A/en
Priority to US08/481,131 priority patent/US6544496B1/en
Priority to JP24222096A priority patent/JP3570650B2/ja
Priority to US08/761,367 priority patent/US5817291A/en
Priority to US08/879,148 priority patent/US6203777B1/en
Priority to US08/915,174 priority patent/US6153172A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Signal Processing (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
SE8307060A 1983-12-21 1983-12-21 Diagnostikum och kontrastmedel SE463651B (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE8307060A SE463651B (sv) 1983-12-21 1983-12-21 Diagnostikum och kontrastmedel
PCT/SE1984/000437 WO1985002772A1 (en) 1983-12-21 1984-12-20 Diagnostic and contrast agent
JP60500230A JPH0755912B2 (ja) 1983-12-21 1984-12-20 診断用造影剤
DE8585900253T DE3475269D1 (en) 1983-12-21 1984-12-20 Diagnostic and contrast agent
EP85900253A EP0166755B2 (en) 1983-12-21 1984-12-20 Diagnostic and contrast agent
AT85900253T ATE38777T1 (de) 1983-12-21 1984-12-20 Diagnose- und kontrastmittel.
NO853270A NO164753C (no) 1983-12-21 1985-08-19 Anvendelse av magnetisk paavirkbart materiale til fremstilling av diagnostisk middel.
DK377085A DK166128C (da) 1983-12-21 1985-08-19 Nmr-kontrastmiddel
FI853207A FI85815C (sv) 1983-12-21 1985-08-21 Användning av magnetiskt känsligt material för framställning av ett me del, som används vid NMR-avbildning
SG856/91A SG85691G (en) 1983-12-21 1991-10-14 Diagnostic and contrast agent
HK134993A HK134993A (en) 1983-12-21 1993-12-09 Diagnostic and contrast agent
US08/361,466 US5618514A (en) 1983-12-21 1994-12-22 Diagnostic and contrast agent
US08/445,945 US5670135A (en) 1983-12-21 1995-05-22 Ultrasonic contrast agent comprising carbohydrate particles
US08/481,131 US6544496B1 (en) 1983-12-21 1995-06-07 Diagnostic and contrast agent
JP24222096A JP3570650B2 (ja) 1983-12-21 1996-09-12 超音波造影法用診断剤
US08/761,367 US5817291A (en) 1983-12-21 1996-12-09 Method of ultrasonic imaging comprising administering biocompatible spheres or particles
US08/879,148 US6203777B1 (en) 1983-12-21 1997-06-19 Method of contrast enhanced magnetic resonance imaging using carbohydrate particles
US08/915,174 US6153172A (en) 1983-12-21 1997-08-20 Reflective microspheres for ultrasonic imaging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8307060A SE463651B (sv) 1983-12-21 1983-12-21 Diagnostikum och kontrastmedel

Publications (3)

Publication Number Publication Date
SE8307060D0 SE8307060D0 (sv) 1983-12-21
SE8307060L true SE8307060L (sv) 1985-06-22
SE463651B SE463651B (sv) 1991-01-07

Family

ID=20353826

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8307060A SE463651B (sv) 1983-12-21 1983-12-21 Diagnostikum och kontrastmedel

Country Status (9)

Country Link
US (1) US6153172A (sv)
EP (1) EP0166755B2 (sv)
JP (2) JPH0755912B2 (sv)
DE (1) DE3475269D1 (sv)
DK (1) DK166128C (sv)
FI (1) FI85815C (sv)
SE (1) SE463651B (sv)
SG (1) SG85691G (sv)
WO (1) WO1985002772A1 (sv)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8408127D0 (en) † 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
DE3577185D1 (de) * 1984-11-01 1990-05-23 Nycomed As Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
PT81498B (pt) * 1984-11-23 1987-12-30 Schering Ag Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
CS255758B1 (en) * 1985-12-11 1988-03-15 Frantisek Rypacek Preparat for the diagnostic of transportion function of oviduct and process for preparing thereof
JPS62153229A (ja) * 1985-12-27 1987-07-08 Nippon Oil Co Ltd 皮膚マ−カ−
US4951675A (en) * 1986-07-03 1990-08-28 Advanced Magnetics, Incorporated Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging
US5314679A (en) * 1986-07-03 1994-05-24 Advanced Magnetics Inc. Vascular magnetic resonance imaging agent comprising nanoparticles
US5102652A (en) * 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US5055288A (en) * 1987-06-26 1991-10-08 Advanced Magnetics, Inc. Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides
US4770183A (en) * 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US5284646A (en) * 1986-07-03 1994-02-08 Advanced Magnetics Inc. Hepatocyte specific receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
USRE35862E (en) * 1986-08-18 1998-07-28 Emisphere Technologies, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
ES2026257T3 (es) * 1987-06-23 1992-04-16 Hafslund Nycomed Innovation Ab Mejoras introducidas en la presentacion de imagenes por resonancia magnetica nuclear.
WO1989006978A1 (en) * 1988-02-05 1989-08-10 Schering Aktiengesellschaft Berlin Und Bergkamen Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents
GB8817137D0 (en) * 1988-07-19 1988-08-24 Nycomed As Compositions
DE68926708T2 (de) 1988-08-04 1996-10-31 Advanced Magnetics Inc Von einem rezeptor induziertes kontrastmittel für den endocytose-typ mri
GB8819753D0 (en) * 1988-08-19 1988-09-21 Nycomed As Apparatus
WO1990001939A1 (en) * 1988-08-19 1990-03-08 Meito Sangyo Kabushiki Kaisha Agent for thermotherapy
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
GB8916780D0 (en) 1989-07-21 1989-09-06 Nycomed As Compositions
US6613306B1 (en) 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US7083778B2 (en) 1991-05-03 2006-08-01 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
GB9007408D0 (en) * 1990-04-02 1990-05-30 Nycomed As Compositions
USRE39146E1 (en) 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US5451410A (en) * 1993-04-22 1995-09-19 Emisphere Technologies, Inc. Modified amino acids for encapsulating active agents
GB9019650D0 (en) 1990-09-07 1990-10-24 Nycomed As Chemical compounds
DK0525199T4 (da) * 1991-01-19 2004-06-01 Meito Sangyo Kk Sammensætning indeholdende ultrafine partikler af magnetisk metaloxid
GB9120508D0 (en) * 1991-09-26 1991-11-06 Nycomed As Diagnostic agents
US5342609A (en) * 1991-10-22 1994-08-30 Mallinckrodt Medical, Inc. Microfluidization of calcium/oxyanion-containing particles
US5344640A (en) * 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging
US5407659A (en) * 1991-10-22 1995-04-18 Mallinckrodt Medical, Inc. Treated calcium/oxyanion-containing particles for medical diagnostic imaging
US5233995A (en) * 1991-11-21 1993-08-10 Sterling Winthrop Inc. Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods
GB9200391D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
GB9200387D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
ES2130406T5 (es) * 1992-08-05 2003-12-16 Meito Sangyo Kk Material compuesto de pequeño diametro compuesto de carboxipolisacarido soluble en agua y oxido de hierro magnetico.
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
DE4309333A1 (de) * 1993-03-17 1994-09-22 Silica Gel Gmbh Superparamagnetische Teilchen, Verfahren zu ihrer Herstellung und Verwendung derselben
TW319763B (sv) 1995-02-01 1997-11-11 Epix Medical Inc
US6589502B1 (en) * 1995-11-27 2003-07-08 International Brachytherapy S.A. Radioisotope dispersed in a matrix for brachytherapy
GB9600427D0 (en) * 1996-01-10 1996-03-13 Nycomed Imaging As Contrast media
JP4280304B2 (ja) 1996-01-10 2009-06-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
CA2265875C (en) 1996-09-09 2007-01-16 Dennis Jay Dupray Location of a mobile station
US9134398B2 (en) 1996-09-09 2015-09-15 Tracbeam Llc Wireless location using network centric location estimators
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19839216C1 (de) * 1998-08-28 2000-01-20 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von sphärischen Mikropartikeln, die ganz oder teilweise aus mindestens einem wasserunlöslichen Verzweigungen enthaltenden Polyglucan bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und die Verwendung
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
AUPR098300A0 (en) 2000-10-25 2000-11-16 Sirtex Medical Limited Polymer based radionuclide containing microspheres
US6797257B2 (en) * 2001-06-26 2004-09-28 The Board Of Trustees Of The University Of Illinois Paramagnetic polymerized protein microspheres and methods of preparation thereof
CA2512454C (en) * 2003-02-04 2012-10-30 Bracco Research Sa Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
WO2004091394A2 (en) * 2003-04-15 2004-10-28 Philips Intellectual Property & Standards Gmbh Method to determine the spatial distribution of magnetic particles and magnetic particle administering compositions
US8651113B2 (en) * 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7723311B2 (en) * 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
EP1701745B1 (en) * 2003-12-22 2014-12-10 Bracco Suisse S.A. Gas-filled microvesicle assembly for contrast imaging
AU2005273865B2 (en) * 2004-08-18 2011-02-24 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
US8669236B2 (en) 2005-05-12 2014-03-11 The General Hospital Corporation Biotinylated compositions
US20070179094A1 (en) 2006-01-31 2007-08-02 Bayer Schering Pharma Ag Modulation of MDL-1 activity for treatment of inflammatory disease
JP6431480B2 (ja) 2012-08-31 2018-11-28 ザ ジェネラル ホスピタル コーポレイション アルツハイマー病の治療および診断のためのビオチン複合体
AU2014228815B2 (en) 2013-03-15 2019-04-18 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
CN113289034A (zh) 2014-12-31 2021-08-24 蓝瑟斯医学影像公司 脂质封装的气体微球组合物及相关方法
EP3361287B1 (en) 2015-10-29 2021-10-13 Huawei Technologies Co., Ltd. Positioning method, base station and server of a mobile network
EP3452108A4 (en) 2016-05-04 2019-12-25 Lantheus Medical Imaging, Inc. METHODS AND DEVICES FOR PREPARING ULTRASONIC CONTRAST AGENTS
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
EP3412303A1 (en) 2017-06-08 2018-12-12 Medizinische Universität Innsbruck Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE372421B (sv) * 1968-04-01 1974-12-23 Minnesota Mining & Mfg
SE420565B (sv) * 1974-06-06 1981-10-19 Pharmacia Ab Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
SE420566B (sv) * 1974-06-06 1981-10-19 Pharmacia Ab Diagnostiseringsmedel for intravaskuler administrering
SE425716B (sv) * 1976-07-05 1982-11-01 Procter & Gamble Fysiologiskt godtagbar, partikelformig berare for teknetium-99m i diagnostiska medel, vilken vesentligen bestar av huvudsakligen vattenlosligt modifierat sterkelsederivat
GB2042887B (en) * 1979-02-22 1983-10-12 New England Nuclear Corp Albumin microaggregates for radioactive scanning of reticuloendothelial systems
US4247406A (en) * 1979-04-23 1981-01-27 Widder Kenneth J Intravascularly-administrable, magnetically-localizable biodegradable carrier
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4265251A (en) * 1979-06-28 1981-05-05 Rasor Associates, Inc. Method of determining pressure within liquid containing vessel
US4316391A (en) * 1979-11-13 1982-02-23 Ultra Med, Inc. Flow rate measurement
US4442843A (en) * 1980-11-17 1984-04-17 Schering, Ag Microbubble precursors and methods for their production and use
US4427646A (en) * 1981-04-02 1984-01-24 Research Corporation Use of radiolabeled peptide derived from crosslinked fibrin to locate thrombi in vivo
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
US4501726A (en) * 1981-11-12 1985-02-26 Schroeder Ulf Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
SE8201972L (sv) * 1982-03-29 1983-09-30 Gambro Lundia Ab Magnetiskt paverkbara kristalliserade kolhydrat sferer eller partiklar att anvendas tillsammans med bioadsorberande material
US4731239A (en) * 1983-01-10 1988-03-15 Gordon Robert T Method for enhancing NMR imaging; and diagnostic use
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5618514A (en) * 1983-12-21 1997-04-08 Nycomed Imaging As Diagnostic and contrast agent
US5720939A (en) * 1985-08-15 1998-02-24 Nycomed Imaging As Method of contrast enhanced magnetic resonance imaging using magnetically responsive-particles
US4767611A (en) * 1984-07-03 1988-08-30 Gordon Robert T Method for affecting intracellular and extracellular electric and magnetic dipoles
DE3577185D1 (de) * 1984-11-01 1990-05-23 Nycomed As Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall

Also Published As

Publication number Publication date
US6153172A (en) 2000-11-28
DK377085D0 (da) 1985-08-19
FI853207A0 (fi) 1985-08-21
DE3475269D1 (en) 1988-12-29
SE463651B (sv) 1991-01-07
JP3570650B2 (ja) 2004-09-29
JPH09110727A (ja) 1997-04-28
EP0166755B1 (en) 1988-11-23
FI85815C (sv) 1992-06-10
DK377085A (da) 1985-08-19
SG85691G (en) 1992-02-14
FI853207L (fi) 1985-08-21
FI85815B (fi) 1992-02-28
EP0166755B2 (en) 1998-06-24
JPS61500786A (ja) 1986-04-24
EP0166755A1 (en) 1986-01-08
DK166128C (da) 1993-08-09
DK166128B (da) 1993-03-15
SE8307060D0 (sv) 1983-12-21
WO1985002772A1 (en) 1985-07-04
JPH0755912B2 (ja) 1995-06-14

Similar Documents

Publication Publication Date Title
SE8307060D0 (sv) Diagnostikum och kontrastmedel
ATE247491T1 (de) Verfahren zur photoakustische bilderzeugung
AU529150B2 (en) Duplex ultrasonic imaging system with repetitive excitation of common transducer in doppler modality
DE59102225D1 (de) Ultraschall-Kontrastmittel, Verfahren zu ihrer Herstellung und Verwendung derselben als Diagnostika und Therapeutika.
JP2014012738A (ja) 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法
BR9814393A (pt) Micropartìculas e uso terapêutico ou diagnóstico delas
JPS56137263A (en) Ultrasonic echo sounding probe having acoustic lens and echo sounder using it
ES2156109T3 (es) Mejoras en o relacionadas con agentes de contraste.
IT7824073A0 (it) Disposizione di trasduttori lineari per formare immagini acustiche olografiche e/o ad eco di impulsi.
IT1232125B (it) Trasduttore elettroacustico, utilizzabile in particolare come sorgente di onde acustiche per applicazioni sottomarine
ES492684A0 (es) Un dispositivo transductor acustico
FR2499806B1 (fr) Transducteur ultrasonique
IT8149539A0 (it) Apparecchio diagnostico ultrasonico e relativo procedimento di diagnosi
JPS5342591A (en) Langevin type ultrasonic vibrator unit
CA999672A (en) Apparatus for coupling an array of ultrasonic transducers to an ultrasonic compressional image field and scanning the image field
IT1123171B (it) Supporto per un trasduttore,per l'emissione e/o la ricezione di segnali ultrasonici in un dato settore angolare
ES511738A0 (es) "un aparato para examinar un objeto por medio de ondas ultrasonicas".
NO871320D0 (no) Anordning for generering av akustiske boelger.
NL7809887A (nl) Inrichting voor de ontwikkeling van acoustische sig- nalen in maritieme omgevingen.
IT1059249B (it) Trasduttore e sistema di emissioni acustiche
DE3574910D1 (de) Geraet zur untersuchung von medien mittels ultraschall-echographie.
Goss et al. Frequency dependence of ultrasonic absorption in mammalian testis
AU571398B2 (en) Examination of objects by ultrasound echography
IT8024423A0 (it) Dispositivo per determinare l'istante di ricezione di un'onda acustica.
JPS53106167A (en) Position locator for sea structure

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8307060-7

Format of ref document f/p: F

NUG Patent has lapsed